I‐Wei Chang
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Hepatology top 10%
- Hepatitis C virus research
Papers in
- Co-authors
- Chien‐Feng Li (19 shared papers)Hong-Lin He (18 shared papers)Wen‐Jeng Wu (9 shared papers)Hsuan‐Ying Huang (2 shared papers)Tingfeng Wu (7 shared papers)Sung‐Wei Lee (8 shared papers)Ming-Tse Sung (1 shared paper)Chi‐Yang Chang (12 shared papers)
- Journals
- Journal of Cancer (9 papers)Tumor Biology (4 papers)Obesity Surgery (3 papers)Gastroenterology (3 papers)Oncotarget (2 papers)
- Partner nations
- TaiwanUnited StatesSweden
In The Last Decade
I‐Wei Chang
60 papers receiving 892 citations
Peers
Comparison fields: 5 of 87
- Cancer Research 140
- Hepatology 72
- Molecular Medicine 32
- Oncology 160
- Pulmonary and Respiratory Medicine 167
Countries citing papers authored by I‐Wei Chang
This map shows the geographic impact of I‐Wei Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I‐Wei Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I‐Wei Chang more than expected).
Fields of papers citing papers by I‐Wei Chang
This network shows the impact of papers produced by I‐Wei Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I‐Wei Chang. The network helps show where I‐Wei Chang may publish in the future.
Co-authors
The 25 scholars most cited alongside I‐Wei Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 49 | |
| 2 | 2009 | 48 | |
| 3 | CDCA5 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder. | 2015 | 48 |
| 4 | 2013 | 41 | |
| 5 | 2016 | 33 | |
| 6 | 2015 | 32 | |
| 7 | 2018 | 31 | |
| 8 | 2015 | 30 | |
| 9 | 2021 | 30 | |
| 10 | 2015 | 28 | |
| 11 | 2016 | 28 | |
| 12 | 2018 | 26 | |
| 13 | 2015 | 24 | |
| 14 | 2016 | 22 | |
| 15 | 2015 | 22 | |
| 16 | 2015 | 22 | |
| 17 | 2018 | 19 | |
| 18 | 2020 | 18 | |
| 19 | 2016 | 18 | |
| 20 | 2015 | 18 |
About I‐Wei Chang
I‐Wei Chang is a scholar working on Surgery, Oncology, Pulmonary and Respiratory Medicine, Epidemiology and Molecular Biology, having authored 69 papers that have together received 899 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (11 papers), Esophageal and GI Pathology (5 papers), Colorectal Cancer Surgical Treatments (5 papers), Liver Disease Diagnosis and Treatment (5 papers), Hepatitis B Virus Studies (3 papers), Bladder and Urothelial Cancer Treatments (3 papers), Gastrointestinal disorders and treatments (3 papers) and Gastric Cancer Management and Outcomes (3 papers). The work is most often cited by research in Cancer Research (140 citations), Hepatology (72 citations), Molecular Medicine (32 citations), Oncology (160 citations) and Pulmonary and Respiratory Medicine (167 citations). I‐Wei Chang has collaborated with scholars based in Taiwan, United States and Sweden. Frequent co-authors include Chien‐Feng Li, Hong-Lin He, Wen‐Jeng Wu, Hsuan‐Ying Huang, Tingfeng Wu, Sung‐Wei Lee, Ming-Tse Sung, Chi‐Yang Chang, Wen‐Lun Wang and Ching‐Tai Lee. Their work appears in journals such as Journal of Cancer, Tumor Biology, Obesity Surgery, Gastroenterology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.